Aldosteronism is an endocrine disorder caused by the hypersecretion of aldosterone, a mineralocorticoid hormone produced by the adrenal cortex. Elevated aldosterone levels lead to sodium and water retention in the body, which in turn causes hypertension and hypokalemia. This condition can be secondary, associated with other pathological processes such as Conn's syndrome or adrenocortical adenoma, or primary, when hormone secretion is not controlled by the renin-angiotensin system. Treatment of aldosteronism involves the use of glucocorticoids, which helps prevent negative consequences of the disease, such as cardiovascular complications and renal failure.
History of the disease and interesting historical facts
Aldosteronism was first described in 1955 by scientists investigating cases associated with hypertension and hypokalemia. It is worth noting that in 1962, British-American endocrinologist Dr. Joan Bendict discovered aldosterone levels in the blood, which greatly contributed to the understanding of this condition. Interestingly, in the era before the discovery of hydrocortisone and other glucocorticoids, aldosterone levels could not be properly controlled, which created difficulties in treating and monitoring patients. Over the next decades, the study of this condition expanded due to the introduction of new laboratory techniques that allow more accurate determination of hormone levels and assessment of functional activity of the adrenal glands.
Epidemiology
According to modern epidemiological data, the prevalence of aldosteronism is about 10% of the total number of cases of arterial hypertension, especially at a young age. Some researchers report higher rates in populations with high stress levels and endocrine disorders. Extensive research shows that among patients with hypertension under 40 years of age, the percentage of aldosteronism can reach 20%, which emphasizes the importance of early diagnosis. In addition, various studies emphasize that the condition is more common in women, especially in the postmenopausal period.
Genetic predisposition to this disease
One of the key elements of genetic predisposition to aldosteronism are mutations in genes responsible for regulation of adrenal function. It is known that lactase deficiency, some forms of hypercortisolism and Lieber syndrome can be the result of hereditary changes. For example, mutations in the KCNJ5 and CACNA1D genes have been associated with the development of adrenocortical tumors. These mutations affect potassium channels and can cause hypersecretion of aldosterone. This confirms the need for genetic screening to identify patients with a high risk of developing aldosteronism.
Risk factors for the development of this disease
There are various risk factors that contribute to the development of aldosteronism, which can be classified as physical, chemical, and lifestyle-related:
- Genetic predisposition: presence of cases of the disease in the family.
- Age: The risk increases with age.
- Obesity: increases the risk of arterial hypertension and, consequently, aldosteronism.
- High-salt diet: Increasing sodium intake may contribute to the development of the disease.
- Toxic substances: exposure to certain chemical components, such as microdoses of drugs and the environment.
- Stress: Chronic stress can activate the renin-angiotensin system.
Diagnosis of this disease
Diagnosis of aldosteronism is based on clinical examination, anamnesis analysis, as well as laboratory and radiological studies. The main symptoms of the disease are:
- Arterial hypertension, especially resistant to therapy.
- Hypokalemia: Leads to muscle weakness and abnormal heart rhythms.
- Feeling of thirst and polyuria.
Laboratory tests include:
- Determination of aldosterone and renin levels in blood plasma.
- Salt load test.
Radiological examinations such as CT scan of the adrenal glands may reveal tumors or other abnormalities. Differential diagnosis includes exclusion of other forms of hypercortisolism and secondary aldosteronism.
Treatment
Treatment of aldosteronism includes both non-pharmacological and pharmacological approaches. Non-pharmacological recommendations:
- Reduce sodium intake in the diet.
- Moderate physical activity.
- Body weight control.
Pharmacological treatment includes mineralocorticoid antagonists, such as spironolactone, and glucocorticoids, which help normalize hormone levels. In severe cases, when drug therapy is ineffective, surgical intervention is indicated - removal of the adrenal tumor or adrenalectomy.
List of medications used to treat this disease
- Spironolactone.
- Eplerenone.
- Dexamethasone.
- Methylprednisolone.
- Ketoconazole.
Disease monitoring
Monitoring aldosteronism is essential to prevent complications. Control steps include:
- Regular measurement of blood pressure.
- Periodic tests for aldosterone and renin levels.
- Evaluation of electrolyte balance and renal function.
The prognosis with timely diagnosis and adequate therapy is favorable in most cases, but the risk of cardiovascular complications remains high. Complications may include strokes, heart attacks, and chronic renal failure.
Age-related features of the disease
Aldosteronism has different manifestations depending on age. In young people, the disease is often associated with genetic factors and less severe symptoms, while in older patients it can manifest itself with more serious arterial disorders and health risks, requiring more complex treatment and monitoring.
Questions and Answers
- What are the main symptoms of aldosteronism? The main symptoms include hypertension, hypokalemia, increased thirst and frequent urination.
- How is the disease diagnosed? Diagnosis includes determination of aldosterone and renin levels, salt loading test and radiological examinations.
- What medications are used to treat aldosteronism? Mineralocorticoid antagonists such as spironolactone and glucocorticoids are used.
- Does aldosteronism affect overall health? Yes, this disease can lead to serious cardiovascular and kidney complications if not treated properly.
- What is the prognosis with adequate treatment? With timely diagnosis and proper treatment, the prognosis is usually favorable, but constant monitoring is required.
Advice from Dr. Oleg Korzhikov
Dear patients, if you have had problems with blood pressure, be sure to consult your doctor about changes in aldosterone levels. Dietary changes play a crucial role in therapeutic control of the condition. Pay attention to your health and express your concerns to your doctor if you notice symptoms such as constant thirst or muscle weakness. Timely treatment can prevent serious complications and normalize the quality of life.
